Towards opioid access without excess

IF 25.2 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Lancet Public Health Pub Date : 2025-02-26 DOI:10.1016/s2468-2667(25)00035-0
William E Rosa, Felicia Marie Knaul, Michael Touchton, Afsan Bhadelia, Keith Humphreys, Lukas Radbruch, M R Rajagopal
{"title":"Towards opioid access without excess","authors":"William E Rosa, Felicia Marie Knaul, Michael Touchton, Afsan Bhadelia, Keith Humphreys, Lukas Radbruch, M R Rajagopal","doi":"10.1016/s2468-2667(25)00035-0","DOIUrl":null,"url":null,"abstract":"A decade after World Health Assembly Resolution 67.19 recognised palliative care as a component of comprehensive care and universal health coverage throughout the life course, a balanced approach to opioid access remains elusive. Disparities in the alleviation of serious health-related suffering persist, characterised by two parallel opioid-related public health crises: a pandemic of unrelieved pain and an opioid addiction epidemic. The pain pandemic is largely driven by the opioid access abyss and primarily affects over 50 million people with serious health-related suffering living in low-income and middle-income countries. Conversely, several high-income countries have been affected by an opioid addiction epidemic. An estimated 39·5 million people struggle with opioid use disorder worldwide, the vast majority living in North America. In this Viewpoint, we describe these parallel crises, argue for pain relief as a global public good, and identify stewardship roles of WHO member states and local actors to use a balanced approach in galvanising the global health system to simultaneously close the global pain divide and move towards opioid access without excess in alignment with Sustainable Development Goal targets focused on the prevention of substance abuse (3.5) and universal health coverage (3.8).","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"185 1","pages":""},"PeriodicalIF":25.2000,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Public Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/s2468-2667(25)00035-0","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

A decade after World Health Assembly Resolution 67.19 recognised palliative care as a component of comprehensive care and universal health coverage throughout the life course, a balanced approach to opioid access remains elusive. Disparities in the alleviation of serious health-related suffering persist, characterised by two parallel opioid-related public health crises: a pandemic of unrelieved pain and an opioid addiction epidemic. The pain pandemic is largely driven by the opioid access abyss and primarily affects over 50 million people with serious health-related suffering living in low-income and middle-income countries. Conversely, several high-income countries have been affected by an opioid addiction epidemic. An estimated 39·5 million people struggle with opioid use disorder worldwide, the vast majority living in North America. In this Viewpoint, we describe these parallel crises, argue for pain relief as a global public good, and identify stewardship roles of WHO member states and local actors to use a balanced approach in galvanising the global health system to simultaneously close the global pain divide and move towards opioid access without excess in alignment with Sustainable Development Goal targets focused on the prevention of substance abuse (3.5) and universal health coverage (3.8).
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
不过量地获取阿片类药物
在世界卫生大会第67.19号决议承认姑息治疗是全面护理和全民健康覆盖整个生命过程的组成部分十年后,对阿片类药物获取的平衡方法仍然难以实现。在减轻与健康有关的严重痛苦方面仍然存在差距,其特点是两种平行的与阿片类药物有关的公共卫生危机:未得到缓解的疼痛大流行和阿片类药物成瘾流行。疼痛大流行在很大程度上是由阿片类药物获取深渊造成的,主要影响到生活在低收入和中等收入国家的5 000多万与健康有关的严重痛苦的人。相反,一些高收入国家受到阿片类药物成瘾流行病的影响。据估计,全世界有3950万人患有阿片类药物使用障碍,其中绝大多数生活在北美。在这一观点中,我们描述了这些平行的危机,认为缓解疼痛是一种全球公共产品,并确定世卫组织会员国和地方行为体的管理作用,以平衡的方式激励全球卫生系统,同时缩小全球疼痛鸿沟,并根据以预防药物滥用(3.5)和全民健康覆盖(3.8)为重点的可持续发展目标目标,无过量地获得阿片类药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Lancet Public Health
Lancet Public Health Medicine-Public Health, Environmental and Occupational Health
CiteScore
55.60
自引率
0.80%
发文量
305
审稿时长
8 weeks
期刊介绍: The Lancet Public Health is committed to tackling the most pressing issues across all aspects of public health. We have a strong commitment to using science to improve health equity and social justice. In line with the values and vision of The Lancet, we take a broad and inclusive approach to public health and are interested in interdisciplinary research. We publish a range of content types that can advance public health policies and outcomes. These include Articles, Review, Comment, and Correspondence. Learn more about the types of papers we publish.
期刊最新文献
Correction to Lancet Public Health 2026; 11: e156-63. Estimated effects of food taxes and subsidies on health, economics, and equity in Australia: a modelling study. Efficacy of front-of-package nutrient labels designed for mandatory implementation in the USA: an online randomised controlled trial. Gender-based violence against women and girls aged ≥15 years presenting to European emergency departments: a multinational, cross-sectional analysis. Front-of-pack food labelling in the USA.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1